Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin Phonophoresis for Chronic Rhinosinusitis
NCT07063082Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jul 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of erythromycin in chronic rhinosinusitis (CRS) (3 arms), sponsored by Cairo University. Primary endpoint: Sinusitis Symptom Score at 1 month. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
erythromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT07063082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07063082.